Hallandale Pharmacy for GLP-1 plus peptide programs

Can Hallandale Pharmacy handle both GLP-1 and peptide orders for the same patient?

Hallandale Pharmacy is a PCAB-accredited 503A compounder that lists both Weight Management (GLP-1 injectables) and Peptide Therapy among its therapeutic categories. For a clinic running semaglutide or tirzepatide alongside peptides like BPC-157, ipamorelin, or NAD+ for the same patient, Hallandale can compound both from one pharmacy — which means one partner portal, one agreement, and one prescription transmission path covering the full stack. The evaluation is whether Hallandale's specific peptide catalog covers your protocols and whether pricing becomes visible before you build per-patient program costs. Pricing requires an account application.

GLP-1 plus peptide programs create the most complex per-patient order profiles in compounding. This page covers whether Hallandale Pharmacy is the right single-compounder source for both and where Fizy Health handles the multi-protocol checkout differently.

Proudly Partnered With

Who this is for

Clinics combining GLP-1 injectables and peptide therapies in one patient program.

A GLP-1 plus peptide program is the most complex per-patient ordering scenario in compounding: a titration-stage semaglutide or tirzepatide vial alongside a rotating peptide stack, all for one patient, from the same prescriber. Three roles manage this complexity.

  • Program designers

    Owners and medical directors designing multi-protocol packages.

    Clinics that combine GLP-1 and peptide therapy price the whole package — semaglutide plus BPC-157 plus ipamorelin — as a per-patient monthly fee. Building that price requires per-compound cost across every item in the protocol, ideally from one compounder. If costs are split across two pharmacy relationships, program pricing becomes harder to manage and reconcile.

  • Operators

    Staff building multi-compound orders for the same patient.

    Ops staff building a multi-protocol order need the GLP-1 and peptide items to appear in one cart for the same patient — not split across separate orders submitted to different pharmacies. If Hallandale's catalog covers both, the partner portal handles it in one submission. If it does not, a second portal splits the order.

  • Prescribers

    Providers coordinating titration and peptide rotation for one patient.

    A prescriber managing a GLP-1 titration and a peptide rotation simultaneously needs accurate SIGs for each compound, sent through one transmission path to one pharmacy. The compounding question is whether Hallandale's catalog supports the peptide concentration your protocol calls for alongside the GLP-1 flex-dose vial.

Whether Hallandale Pharmacy can source both GLP-1s and peptides

Hallandale compounds semaglutide and tirzepatide in multiple flex-dose vial formats and lists Peptide Therapy as a therapeutic category. For a clinic whose GLP-1 plus peptide program uses compounds in both categories — for example, tirzepatide flex-dose alongside BPC-157 or ipamorelin — Hallandale may be able to source the full per-patient stack from one pharmacy. The critical check is whether the specific peptides in your protocol are in Hallandale's active catalog at the concentrations you need, since peptide availability can change with supply and regulatory conditions.

If your peptide list is fully covered by Hallandale, a single-compounder relationship simplifies the multi-protocol program significantly: one account, one pricing agreement, one submission portal, and one shipping lane for the full patient stack. That simplicity matters when you are managing a protocol that already has clinical complexity.

What happens when your peptide stack is not fully in Hallandale's catalog

Not every peptide a clinic uses is in every 503A compounder's active catalog. If one compound in your stack — a specific sermorelin concentration, an AOD-9604 formulation, or a combination peptide — is not available from Hallandale, you will need a second pharmacy portal for that specific item, which splits the patient's order across two systems. Managing a split per-patient order — GLP-1 from Hallandale, one peptide from a second compounder — means two order submissions, two tracking records, and two invoices that must be reconciled to a single patient chart.

Fizy Health handles this split transparently: if different compounds in the same patient's protocol come from different 503A partners, they go into one clinic cart and check out together. The per-vial cost for each compound — GLP-1 from one partner, peptide from another — is visible before checkout, and the full order is validated before payment. For a clinic managing multi-protocol per-patient programs, that consolidation reduces the administrative overhead that a split-pharmacy setup creates.

Pick the pharmacy source that covers your full GLP-1 plus peptide stack.

Hallandale Pharmacy fits if

Hallandale Pharmacy

Hallandale's catalog covers both your GLP-1 and peptide protocols from one compounder.

  • Your peptide stack — the specific compounds, concentrations, and vial sizes — is confirmed available in Hallandale's active catalog.
  • You want one compounder for the full per-patient stack and Hallandale can source it without a second pharmacy portal.
  • You are comfortable completing an account application before seeing per-compound pricing for the full protocol.
Consider Fizy Health if

Fizy Health

You need one cart for the full multi-protocol patient order across multiple 503A partners.

  • Your GLP-1 and peptide stack spans more than one 503A compounder and you need one cart for the full per-patient order.
  • You want per-compound cost visible before checkout so the full program fee is built on real numbers.
  • You want pre-payment validation across the entire multi-protocol order so a wrong peptide concentration is caught before payment.
FAQ

GLP-1 plus peptide program questions about Hallandale Pharmacy.

  • Coverage

    Can Hallandale Pharmacy compound both GLP-1s and peptides for the same patient?

    Hallandale Pharmacy lists both Weight Management (GLP-1 injectables) and Peptide Therapy as therapeutic categories. For the same patient receiving semaglutide or tirzepatide alongside a peptide stack, Hallandale may be able to compound both from one pharmacy — but confirm the specific peptides in your protocol are in the active catalog at the concentrations you need before relying on it as a sole source.

  • GLP-1 products

    What GLP-1 vials does Hallandale Pharmacy offer for multi-protocol programs?

    Hallandale's GLP-1 catalog includes semaglutide flex-dose vials at 2.5 mg/mL (1–4 mL sizes) and a double-strength version at 5 mg/mL (3 mL), and tirzepatide flex-dose vials at 10 mg/mL (1–4 mL) plus a Forte at 15 mg/mL (4 mL). The flex-dose format allows multiple titration draws from one vial, reducing the number of separate GLP-1 line items per patient over a titration program.

  • Peptide availability

    How do I confirm Hallandale Pharmacy carries the specific peptides I need?

    Hallandale lists Peptide Therapy as a therapeutic area but does not publish a complete peptide formulary publicly. Contact Hallandale's clinical or sales team during the account application process to confirm specific compounds (BPC-157, ipamorelin, sermorelin, NAD+, etc.) are in active production at your needed concentrations before building them into a patient protocol.

  • Multi-pharmacy

    What if one peptide in my stack is not available from Hallandale?

    If a specific peptide is not in Hallandale's active catalog, you need a second pharmacy portal for that compound — which splits the patient's full protocol across two ordering systems. Fizy Health consolidates multi-compounder orders into one cart so the GLP-1 and any peptide from a different partner check out together.

  • Pricing

    Can I see per-compound pricing before building a GLP-1 plus peptide program fee?

    No. Hallandale's pricing requires account enrollment before any per-compound rate is shared. For a clinic building a combined program fee — semaglutide plus peptides — the inability to see the full per-patient compounded cost before enrollment is the main friction point. Fizy Health shows pass-through per-vial cost for each compound before checkout.

  • Workflow

    How are multi-protocol orders submitted to Hallandale in one session?

    If both the GLP-1 and the peptide are available from Hallandale, a prescriber submits via LifeFile ERX, Surescripts, EMR API, or fax in one transmission — no need to separate them. The portal should route both compounds through one order if they are both in Hallandale's catalog. Confirm this works for your specific compound combination in an account demo.

  • Alternative

    How does Fizy Health compare for GLP-1 plus peptide programs?

    Fizy Health consolidates the full per-patient multi-protocol order — GLP-1 and all peptides, from any combination of 503A partners — into one validated cart with pass-through per-compound cost visible before checkout and pre-payment validation across the full stack. For clinics whose protocols span more than one compounder, Fizy Health eliminates the split-portal overhead.

Sources reviewed June 2026

  • Hallandale Pharmacy public website (hallandalerx.com) and partner portal (partner.hallandalerx.com), reviewed June 2026.
  • Hallandale Pharmacy PCAB accreditation verified via ACHC directory; Florida license PH28017 verified via FL DOH MQA portal, June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

Build one per-patient program price for GLP-1 and peptides together.

See per-compound cost on the full stack before checkout, one cart for the entire protocol, and validation before you pay. Free to start.